Education
About Us
Working with TipRanks
Follow Us
Roivant Sciences (ROIV)
NASDAQ:ROIV
Total Valuation
Roivant Sciences has a market cap or net worth of $19.18B. The enterprise value is $17.66B.
Market Cap$19.18B
Enterprise Value$17.66B
Share Statistics
Roivant Sciences has 715,701,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding715,701,100
Owned by Insiders20.23%
Owned by Institutions12.29%
Financial Efficiency
Roivant Sciences’s return on equity (ROE) is -0.04 and return on invested capital (ROIC) is -18.94%.
Return on Equity (ROE)-0.04
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-18.94%
Return on Capital Employed (ROCE)-0.19
Revenue Per Employee32.00K
Profits Per Employee-392.88K
Employee Count908
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Roivant Sciences is ―. Roivant Sciences’s PEG ratio is 0.41.
PE Ratio―
PS Ratio251.93
PB Ratio1.56
Price to Fair Value1.56
Price to FCF-8.67
Price to Operating Cash Flow-24.28
PEG Ratio0.41
Income Statement
In the last 12 months, Roivant Sciences had revenue of 29.05M and earned -171.98M in profits. Earnings per share was -0.24.
Revenue29.05M
Gross Profit28.14M
Operating Income-1.00B
Pretax Income-681.59M
Net Income-171.98M
EBITDA-1.10B
Earnings Per Share (EPS)-0.24
Cash Flow
In the last 12 months, operating cash flow was -759.10M and capital expenditures -7.76M, giving a free cash flow of -766.86M billion.
Operating Cash Flow-759.10M
Free Cash Flow-766.86M
Free Cash Flow per Share-1.07
Dividends & Yields
Roivant Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.79
52-Week Price Change153.31%
50-Day Moving Average22.36
200-Day Moving Average15.95
Relative Strength Index (RSI)69.84
Average Volume (3m)6.32M
Important Dates
Roivant Sciences upcoming earnings date is Jul 1, 2026, Before Open (Confirmed).
Last Earnings DateFeb 6, 2026
Next Earnings DateJul 1, 2026
Ex-Dividend Date―
Financial Position
Roivant Sciences as a current ratio of 33.47, with Debt / Equity ratio of 4.86%
Current Ratio33.47
Quick Ratio33.47
Debt to Market Cap<0.01
Net Debt to EBITDA2.38
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Roivant Sciences has paid 48.17M in taxes.
Income Tax48.17M
Effective Tax Rate-0.07
Enterprise Valuation
Roivant Sciences EV to EBITDA ratio is -4.28, with an EV/FCF ratio of -5.57.
EV to Sales161.91
EV to EBITDA-4.28
EV to Free Cash Flow-5.57
EV to Operating Cash Flow-5.60
Balance Sheet
Roivant Sciences has $4.53B in cash and marketable securities with $207.44M in debt, giving a net cash position of $4.32B billion.
Cash & Marketable Securities$4.53B
Total Debt$207.44M
Net Cash$4.32B
Net Cash Per Share$6.04
Tangible Book Value Per Share$7.15
Margins
Gross margin is 91.21%, with operating margin of -3453.32%, and net profit margin of -591.96%.
Gross Margin91.21%
Operating Margin-3453.32%
Pretax Margin-2346.02%
Net Profit Margin-591.96%
EBITDA Margin-3784.84%
EBIT Margin-3833.27%
Analyst Forecast
The average price target for Roivant Sciences is $32.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$32.00
Price Target Upside19.40% Upside
Analyst ConsensusStrong Buy
Analyst Count9
Revenue Growth Forecast-83.82%
EPS Growth Forecast-109.22%